| Literature DB >> 26817421 |
S M Masud Karim1, Lin Liu2, Thuc Duy Le3, Jiuyong Li4.
Abstract
BACKGROUND: microRNAs (miRNAs) play an essential role in the post-transcriptional gene regulation in plants and animals. They regulate a wide range of biological processes by targeting messenger RNAs (mRNAs). Evidence suggests that miRNAs and mRNAs interact collectively in gene regulatory networks. The collective relationships between groups of miRNAs and groups of mRNAs may be more readily interpreted than those between individual miRNAs and mRNAs, and thus are useful for gaining insight into gene regulation and cell functions. Several computational approaches have been developed to discover miRNA-mRNA regulatory modules (MMRMs) with a common aim to elucidate miRNA-mRNA regulatory relationships. However, most existing methods do not consider the collective relationships between a group of miRNAs and the group of targeted mRNAs in the process of discovering MMRMs. Our aim is to develop a framework to discover MMRMs and reveal miRNA-mRNA regulatory relationships from the heterogeneous expression data based on the collective relationships.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26817421 PMCID: PMC4895272 DOI: 10.1186/s12864-015-2300-z
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1DICORE workflow. Given the inputs of miRNA and mRNA expression profiles, we first derive an expression-based interaction weights matrix W using correlation test. We then compute two collaboration score matrices S and T from W for miRNAs and mRNAs based on their functional interaction similarities with common mRNAs (or miRNAs), respectively. Using these collaboration scores as input, we separately generate groups of miRNAs and groups of mRNAs at Stage 1 by an overlapping neighborhood expansion clustering algorithm, in which miRNAs or mRNAs are greedily added to (removed from) each cluster of miRNAs or mRNAs, respectively that maximize cohesiveness score of the cluster. Next in Stage 2, we apply canonical correlation analysis on the groups of miRNAs and groups of mRNAs to obtain significant collective group relationships, which are eventually the MMRMs with strength scores
Summary of results of DICORE on the NCI60 dataset
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| 0.45 | 1 | 6.00 | 35.00 | 0.61 | 1142.88 |
| 0.50 | 4 | 8.50 | 32.00 | 0.64 | 635.31 |
| 0.55 | 3 | 11.67 | 27.00 | 0.69 | 246.17 |
| 0.60 | 8 | 57.00 | 19.00 | 0.80 | 80.89 |
| 0.65 | 6 | 83.67 | 10.50 | 0.79 | 86.95 |
| 0.70 | 4 | 107.50 | 6.25 | 0.81 | 24.30 |
| 0.75 | 4 | 44.00 | 5.00 | 0.87 | 4.78 |
| 0.80 | 2 | 22.50 | 5.00 | 0.91 | 2.44 |
| 0.85 | 1 | 12.00 | 5.00 | 0.95 | 0.90 |
Summary of results of DICORE on the BR dataset
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| 0.50 | 3 | 8.00 | 15.00 | 0.66 | 1938.13 |
| 0.55 | 44 | 23.57 | 6.18 | 0.63 | 2043.01 |
| 0.60 | 33 | 48.09 | 6.61 | 0.70 | 216.53 |
| 0.65 | 24 | 47.79 | 3.00 | 0.69 | 36.49 |
Summary of results of DICORE on the MCC dataset
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| 0.40 | 7 | 15.71 | 35.00 | 0.58 | 354.30 |
| 0.45 | 10 | 84.70 | 20.40 | 0.58 | 540.36 |
| 0.50 | 5 | 30.40 | 29.00 | 0.72 | 12.40 |
| 0.55 | 1 | 55.00 | 25.00 | 0.80 | 4.18 |
| 0.60 | 1 | 19.00 | 9.00 | 0.82 | 1.45 |
Confirmed interactions in COREs from the NCI60 for η=0.65 (Continued)
| SACS, SLC29A2, TBC1D30 | |
|
| |
| MAP1B, MARK2, PARD6B; | |
|
| |
|
| |
| GCNT3, GRHL2, ITGB4, MANSC1, MCF2L, OVOL1, | |
| PARD6B, PLS1, PPL, QKI, RAB32, RAB8B, | |
| SACS, SLC20A1, TC2N, VIM; | |
|
| |
| RHOD, SLC20A1, TUBA1A, VIM; | |
| C4N65 |
|
| C5N65 |
|
|
| |
|
|
miRNAs are highlighted in bold-face texts
Fig. 2Confirmed interactions for miRNAs of the miR-200 family included in the top CORE ‘C1N65’ obtained from the NCI60. Red nodes are miRNAs, and green nodes are experimentally confirmed target mRNAs
Top 7 enrichment KEGG pathways for CORE ‘C1N60’ from the NCI60 for η=0.60
| No | KEGG Pathways |
|
|---|---|---|
| 1 | Tight junction | 9.28E–08 |
| 2 | Arrhythmogenic right ventricular | 5.73E–04 |
| cardiomyopathy (ARVC) | ||
| 3 | Glutathione metabolism | 3.40E–03 |
| 4 | Leukocyte transendothelial migration | 4.84E–03 |
| 5 | Axon guidance | 8.35E–03 |
| 6 | Pathways in cancer | 1.01E–02 |
| 7 | Endocytosis | 1.44E–02 |
Top 7 enrichment KEGG pathways for CORE ‘C1B60’ from the BR for η=0.60
| No | KEGG Pathways |
|
|---|---|---|
| 1 | Inositol phosphate metabolism | 2.44E–02 |
| 2 | Complement and coagulation cascades | 3.01E–02 |
| 3 | Regulation of actin cytoskeleton | 3.42E–02 |
| 4 | Phosphatidylinositol signaling system | 3.59E–02 |
| 5 | Pathways in cancer | 4.05E–02 |
| 6 | ECM-receptor interaction | 4.44E–02 |
| 7 | Prostate cancer | 4.59E–02 |
Top 7 enrichment KEGG pathways for CORE ‘C1M45’ from the MCC for η=0.45
| No | KEGG Pathways |
|
|---|---|---|
| 1 | Vascular smooth muscle contraction | 3.85E–08 |
| 2 | Oocyte meiosis | 6.07E–04 |
| 3 | Complement and coagulation cascades | 2.37E–03 |
| 4 | Adherens junction | 2.41E–03 |
| 5 | Long-term depression | 2.52E–03 |
| 6 | Pathways in cancer | 3.05E–03 |
| 7 | Tight junction | 4.46E–03 |
GeneGo mapped pathways for CORE ‘C1N65’ from the NCI60 for η=0.65
| No | Pathway maps |
|
|---|---|---|
| 1 | Development_miRNA-dependent inhibition of EMT | 3.38E–12 |
| 2 | Cytoskeleton remodelling_Keratin filaments | 2.41E–11 |
| 3 | Cell adhesion_Endothelial cell contacts by junctional mechanisms | 1.03E–07 |
| 4 | Cell adhesion_Tight junctions | 8.05E–07 |
| 5 | Cell adhesion_Gap junctions | 1.54E–04 |
| 6 | Development_Neural stem cell lineage commitment (schema) | 3.92E–04 |
| 7 | Cell cycle_Role of 14–3–3 proteins in cell cycle regulation | 1.03E–03 |
| 8 | Hypoxia–induced EMT in cancer and fibrosis | 2.90E–03 |
| 9 | LRRK2 in neurons in Parkinson’s disease | 3.39E–03 |
| 10 | G–protein signaling_RhoA regulation pathway | 3.69E–03 |
| 11 | Development_TGF– | 4.01E–03 |
| 14 | Development_TGF– | 9.18E–03 |
| 20 | Development_Regulation of EMT | 2.11E–02 |
Fig. 3Predicted interactions for miRNAs included in the top CORE ‘C1N65’ obtained from the NCI60. Red nodes are miRNAs, yellow and white nodes are predicted (conserved) targets and poorly conserved targets of conserved miRNA families, respectively. Solid lines and dashed lines are used to represent links between miRNAs and their conserved targets and poorly conserved targets, respectively. The interactions are predicted by both DICORE and TargetScan
Performance of DICORE, Mirsynergy, SNMNMF, and PIMiM
| Method |
|
|
|
|---|---|---|---|
|
| 56 | 8.30 | 43.83 |
|
| 84 | 4.76 | 7.57 |
|
| 49 | 4.12 | 81.37 |
|
| 40 | 4.70 | 67.80 |
Top enrichment KEGG pathways for ‘C9O35’ from the OVC for η=0.35
| No | KEGG Pathways |
|
|---|---|---|
| 1 | Basal cell carcinoma | 3.85E–08 |
| 2 | Arginine and proline metabolism | 0.0298836 |
| 3 | Glutathione metabolism | 0.0398112 |
| 4 | Pathways in cancer | 0.0426415 |
| 5 | Cell cycle | 0.0495754 |
Top enrichment KEGG pathways for ‘C17O35’ from the OVC for η=0.35
| No | KEGG Pathways |
|
|---|---|---|
| 1 | Pathways in cancer | 0.00679353 |
| 2 | MAPK signaling pathway | 0.0136845 |
Confirmed interactions in COREs from the NCI60 for η=0.65
| ID | Confirmed interactions |
|---|---|
| C1N65 |
|
| PARD6B, RAB32, RAB8B, RHOD, SLC20A1, | |
| TWIST1; | |
|
| |
| KLF5, MAL2, MAP1B, QKI, RAB8B, ST14, | |
| TBC1D30, TRAF4; | |
|
| |
| ITGB4, MAP1B, MSN, PARD6B, RAB32, TWIST1; | |
|
| |
| ELOVL5, ENSA, EPCAM, ESRP2, KIAA1949, KLF5, | |
| MAL2, MAP1B, MAPK13, MSN, OSTM1, PARD6B, | |
| QKI, SACS, SLC20A1, TINAGL1, TTL, TWIST1; | |
|
| |
| OSTM1, PARD6B, QKI, SLC20A1, ST14, TPD52L1, | |
| TWIST1, VIM; | |
|
| |
| OVOL1, PARD6B, TC2N, TPD52L1, VIM; | |
|
| |
| MAL2, MAP1B, MAP7, PRRG4, SLC20A1, TRAF4, | |
| TTL, TWIST1; | |
|
| |
| TTL; | |
|
| |
| SACS, TWIST1, VIM; | |
|
| |
|
| |
| PARD6B, RAB8B, RBM47, SACS, SLC20A1; | |
|
| |
| F11R, FAM83H, FAM84B, GRHL1, GSR, LPAR2, | |
| MAP1B, MYO5B, PARD6B, PLS1, QKI, RAB11FIP4, | |
| S100A14, SACS, SLC29A2, TRAF4; | |
| C2N65 |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
| C3N65 |
|
| RAB8B, SACS, SLC29A2, TST; | |
|
| |
| GIPC2, KIAA1522, MAP7, MCF2L, MPZL2, MYO5B, | |
| OSTM1, PARD6B, PLS1, RAB8B, RBM47, S100P, |